In a bid to combat corruption and promote accountability in Liberia’s forestry sector, Integrity Watch Liberia has concluded a two-day capacity-building workshop aimed at training over 20 ...

Despite what critics might claim about supposed “cuts” to scientific research under the Trump administration, what we are seeing now with the FDA’s talc inquiry is how government should ...

VAMBO TOWNSHIP – Eleven townspeople have been elected to a community forest leadership in Grand Bassa County, calming months of tension over their towns’ alleged misrepresentation. By Emmanuel Sherman ...

As part of its chemicals in food program the FDA ensures exposure to chemicals is safe. This includes chemicals authorized for use in and with foods during food packaging, processing or other ...

The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with systemic corticosteroids, Sanofi and Regeneron announced. The FDA’s ...

FDA approves Yeztugo as the first U.S. twice-yearly injectable for HIV prevention, showing 99.9% efficacy and broad access for all patients.

FDA approves new indication for Keytruda The approval introduces the first perioperative anti-PD-1 treatment regimen for adults with resectable locally advanced head and neck squamous cell carcinoma.

FDA Offers Speedier Approvals to Drug Companies Aligning With ‘National Priorities’ June 20, 2025 ...

FDA approves new twice-yearly HIV prevention shot. Here's how it works By Daniel Miller Published June 19, 2025 10:56am EDT Health ...

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

FDA Approves Powerful Twice-Yearly Treatment to Prevent HIV Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections By Joseph Walker and ...

Nationwide, hospitals and pharmacies are seeing ongoing shortages of medications including some anesthetics, antibiotics, opioids and chronic disease treatments, FDA data shows. As of June 19, 194 ...